Skip to main content
. 2021 Sep 3;100(35):e26873. doi: 10.1097/MD.0000000000026873

Table 2.

Adverse events.

Items Control group (N = 63) Meloxicam group (N = 65) P value
Nausea, no. (%) 22 (34.9) 17 (26.2) .281
Vomiting, no. (%) 8 (12.7) 6 (9.2) .530
Constipation, no. (%) 16 (25.4) 12 (18.5) .343
Drowsiness, no. (%) 3 (4.8) 5 (7.7) .494
Dizziness, no. (%) 3 (4.8) 4 (6.2) .729